Global Immunoassay Market - Forecasts from 2018 to 2023

October 2018 | 99 pages | ID: G669A99962AEN
Knowledge Sourcing Intelligence LLP

Abstracts

The global immunoassay market is projected to grow at a CAGR of 7.15% during the forecast period of 2017-2023. Immunoassays are bioanalytical methods that capitalizes on the specificity of the antibody-antigen binding found naturally in the immune system and are highly sensitive and specific. Immunoassay methods are capable of quantifying wide variety of compounds such as low molecular weight drugs, macromolecular biomolecules, and biomarkers which indicate disease diagnosis or prognosis. These assays are highly adaptable and can be applied to wide areas such as diagnosis of the disease, clinical pharmacokinetics, bioequivalence studies and therapeutic drug monitoring. Immunoassays measure the formation of antibody-antigen complexes and detect them via an indicator reaction. The growth in the market may be attributed to the rise in the prevalence of chronic and infectious diseases which require immunoassays for the diagnosis. Technological advancements in the field of immunoassays coupled with the growth in biotechnology and biopharmaceutical industries will further boost the market during the given forecast period. However, stringent regulatory requirements and unfavourable reimbursement policies in many countries might restrain the immunoassay market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global immunoassays market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global immunoassays market.

Major industry players profiled as part of the report are Roche Diagnostics, Quidel Corporation and Omega Diagnostics Group PLC among others.

Segmentation

• By Technology
• Radioimmunoassay (RIA)
• Counting Immunoassay (CIA)
• Enzyme Immunoassays (EIA) or Enzyme-linked immunosorbent assays (ELISA)
• Fluoroimmnoassay (FIA)
• Chemiluminescence immunoassay (CLIA)
• By Therapeutic Area
• Infectious Diseases
• Bone Metabolism
• Immunology
• Neurobiology
• Others
• By End-User Industry
• Hospitals and Clinics
• Diagnostics
• Pharmaceutical and Biotechnology Companies
• Research & Academic Laboratories
• By Geography
• North America
• United States
• Canada
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Australia
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL IMMUNOASSAY MARKET FORECAST BY TECHNIQUE

5.1. Radioimmunoassay (RIA)
5.2. Counting Immunoassay (CIA)
5.3. Enzyme Immunoassays (EIA) or Enzyme-linked immunosorbent assays (ELISA)
5.4. Fluoroimmnoassay (FIA)
5.5. Chemiluminescence immunoassay (CLIA)

6. GLOBAL IMMUNOASSAY MARKET FORECAST BY THERAPEUTIC AREA

6.1. Infectious Diseases
6.2. Bone Metabolism
6.3. Immunology
6.4. Neurobiology
6.5. Others

7. GLOBAL IMMUNOASSAY MARKET FORECAST BY END-USER

7.1. Hospitals and Clinics
7.2. Diagnostics
7.3. Pharmaceutical and Biotechnology Companies
7.4. Research & Academic Laboratories

8. GLOBAL IMMUNOASSAY MARKET FORECAST BY GEOGRAPHY

8.1. North America
  8.1.1. The U.S
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. U.K.
  8.3.2. France
  8.3.3. Germany
  8.3.4. Italy
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. UAE
  8.4.3. Israel
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Australia
  8.5.4. South Korea
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. COMPANY PROFILES

10.1. Fujirebio
  10.1.1. Overview
  10.1.2. Financials
  10.1.3. Product and Services
  10.1.4. Recent Developments
10.2. Quidel Corporation
  10.2.1. Overview
  10.2.2. Financials
  10.2.3. Product and Services
  10.2.4. Recent Developments
10.3. Roche Diagnostics
  10.3.1. Overview
  10.3.2. Financials
  10.3.3. Product and Services
  10.3.4. Recent Developments
10.4. Immunodiagnostic Systems
  10.4.1. Overview
  10.4.2. Financials
  10.4.3. Product and Services
  10.4.4. Recent Developments
10.5. Arbor Assays
  10.5.1. Overview
  10.5.2. Financials
  10.5.3. Product and Services
  10.5.4. Recent Developments
10.6. Omega Diagnostics Group PLC
  10.6.1. Overview
  10.6.2. Financials
  10.6.3. Product and Services
  10.6.4. Recent Developments
10.7. Beckman Coulter, Inc.
  10.7.1. Overview
  10.7.2. Financials
  10.7.3. Product and Services
  10.7.4. Recent Developments
10.8. ImmunoReagents, Inc.
  10.8.1. Overview
  10.8.2. Financials
  10.8.3. Product and Services
  10.8.4. Recent Developments
10.9. Aushon BioSystems
  10.9.1. Overview
  10.9.2. Financials
  10.9.3. Product and Services
  10.9.4. Recent Developments
10.10. Mercodia AB
  10.10.1. Overview
  10.10.2. Financials
  10.10.3. Product and Services
  10.10.4. Recent Developments
List of Figures
List of Tables